Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 30, 2026 09:30 ET | Source: Les Entreprises Yanik Guillemette

Yanik Guillemette — "Canada Slips Into Recession While Ottawa Bills $200,000 for In-Flight Luxury Meals"

Le Canada plonge en récession technique. Yanik Guillemette sonne l'alarme et dénonce l'incompétence d'Ottawa et ses repas à 200 000 $ en jet.
May 30, 2026 09:30 ET | Source: SNS Insider pvt ltd

Ethylene Market Projected to Reach USD 332.61 Billion by 2035 | SNS Insider

Austin, May 30, 2026 (GLOBE NEWSWIRE) -- The Ethylene Market size was valued at USD 187.35 billion in 2025 and is expected to reach USD 332.61 billion by 2035, growing at a CAGR of 5.99% over the...
May 30, 2026 09:30 ET | Source: SNS Insider pvt ltd

Laundry Detergents Market to Reach USD 131.49 Billion by 2035 Amid Rising Demand for Liquid Pods and Premium Fabric Care Solutions | Report by SNS Insider

Austin, May 30, 2026 (GLOBE NEWSWIRE) -- The Laundry Detergents Market size was valued at USD 79.2 billion in 2025 and is expected to reach USD 131.49 billion by 2035, growing at a CAGR of 5.20%...
May 30, 2026 09:00 ET | Source: Momcozy

Momcozy Launches Plus Baby Wipes Built for Every “Messy Milestone”: 99% Purified Water, 8″ × 8″, Independently Certified by Intertek

LOS ANGELES, May 30, 2026 (GLOBE NEWSWIRE) -- Momcozy, the globally recognized mother-and-baby brand known for its wearable breast pump line, today announced the global launch of Momcozy Plus Baby...
May 30, 2026 08:25 ET | Source: AIX Alpha

AI Bots Takes Over XRP Trading as AIX Alpha Launches Its Next‑Gen Automation System

LOS ANGELES, May 30, 2026 (GLOBE NEWSWIRE) -- For many traders, one challenge is becoming increasingly clear: digital asset markets no longer move in predictable patterns. XRP experienced renewed...
May 30, 2026 08:00 ET | Source: https://immatics.com/

Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting

One-time infusion of IMA203CD8 PRAME cell therapy in the ongoing Phase 1 dose escalation/dose expansion trial achieved anti-tumor activity in platinum-resistant ovarian cancer and in uterine cancer...
May 30, 2026 08:00 ET | Source: Replimune, Inc.

Replimune Presents 3-Year Landmark Overall Survival Analysis from IGNYTE Clinical Trial During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

WOBURN, Mass., May 30, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today...
May 30, 2026 08:00 ET | Source: Molecular Partners

Molecular Partners Holds Presentations at ASCO and SNMMI 2026 on DLL3-Targeting Radio-DARPin MP0712, Now Dosing Patients in Phase 1

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., May 30, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage...
May 30, 2026 08:00 ET | Source: The Family Health Centers of Georgia, Inc.

Atlanta Based Health Center celebrates 50 Years of Service

Atlanta, Georgia, May 30, 2026 (GLOBE NEWSWIRE) -- “Reaching half of a decade is an incredible milestone,” proudly stated Dr. Michael W. Brooks, MD, MBA, The Family Health Centers of Georgia’s...
May 30, 2026 08:00 ET | Source: Cogent Biosciences, Inc.

Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Bezuclastinib combination is first treatment ever to demonstrate statistically significant advantage against active comparator in GIST patients; median PFS of 16.5 months versus 9.2 months (HR=0.50,...